[HTML][HTML] Mucormycosis and COVID-19 pandemic: Clinical and diagnostic approach

A Azhar, WH Khan, PA Khan, K Alhosaini… - Journal of Infection and …, 2022 - Elsevier
The pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is
yet to be controlled worldwide, especially in India. The second wave of coronavirus disease …

Mucormycosis and COVID‐19: an epidemic within a pandemic in India

L Selarka, S Sharma, D Saini, S Sharma, A Batra… - Mycoses, 2021 - Wiley Online Library
Abstract Importance Coronavirus disease (COVID‐19) causes an immunosuppressed state
and increases risk of secondary infections like mucormycosis. We evaluated clinical …

[HTML][HTML] Coronavirus disease-associated mucormycosis from a tertiary care hospital in India: a case series

Y Singh, V Ganesh, S Kumar, N Patel, R Aggarwala… - Cureus, 2021 - ncbi.nlm.nih.gov
Background: Coronavirus disease (COVID-19) remains a health concern with new
challenges emerging as the pandemic progresses. The recent rise of opportunistic infections …

COVID-19 associated multisystemic mucormycosis from India: a multicentric retrospective study on clinical profile, predisposing factors, cumulative mortality and …

M Sahu, M Shah, VR Mallela, VR Kola, HK Boorugu… - Infection, 2023 - Springer
Purpose The clinical course of COVID-19 has been complicated by secondary infections,
including bacterial and fungal infections. The rapid rise in the incidence of invasive …

Risks of mucormycosis in the current Covid-19 pandemic: a clinical challenge in both immunocompromised and immunocompetent patients

P Monika, MN Chandraprabha - Molecular Biology Reports, 2022 - Springer
Abstract Mucormycosis, also called “Black Fungus”, is a new cause for worry in the current
Coronavirus disease 2019 (covid-19) pandemic. Mucormycosis is devasting due to its high …

[HTML][HTML] Mucormycosis an added burden to Covid-19 Patients: An in-depth systematic review

NN Shah, Z Khan, H Ahad, AY Elderdery… - Journal of infection and …, 2022 - Elsevier
Abstract As of 25th July, 2022, global Disease burden of 575,430,244 confirmed cases and
over 6,403,511 deaths have been attributed to coronavirus disease 2019 (COVID-19). Co …

Mucormycosis and COVID-19-associated mucormycosis: insights of a deadly but neglected mycosis

LC García-Carnero, HM Mora-Montes - Journal of Fungi, 2022 - mdpi.com
The ongoing COVID-19 pandemic has quickly become a health threat worldwide, with high
mortality and morbidity among patients with comorbidities. This viral infection promotes the …

[HTML][HTML] Mucormycosis in COVID-19 pandemic: Risk factors and linkages

M Kumar, DK Sarma, S Shubham, M Kumawat… - Current Research in …, 2021 - Elsevier
Mucormycosis is a serious and potentially fatal fungal infection caused by a type of rare but
opportunistic fungal pathogen called mucormycetes. Recently, mucormycosis, also known …

Mucormycosis in the COVID-19 environment: a multifaceted complication

R Sharma, P Kumar, A Rauf, A Chaudhary… - Frontiers in cellular …, 2022 - frontiersin.org
The second wave of coronavirus disease 2019 (COVID-19) caused severe infections with
high mortality. An increase in the cases of COVID-19-associated mucormycosis (CAM) was …

[HTML][HTML] Rampant increase in cases of mucormycosis in India and Pakistan: a serious cause for concern during the ongoing COVID-19 pandemic

BK Ghazi, S Rackimuthu, UU Wara… - The American Journal …, 2021 - ncbi.nlm.nih.gov
COVID-19 is a global health crisis that continues to pose new challenges all around the
world. Amidst the growing pandemic, a spike in the number of mucormycosis cases in India …